1. Home
  2. RGEN vs ESAB Comparison

RGEN vs ESAB Comparison

Compare RGEN & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ESAB
  • Stock Information
  • Founded
  • RGEN 1981
  • ESAB 1904
  • Country
  • RGEN United States
  • ESAB United States
  • Employees
  • RGEN N/A
  • ESAB N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ESAB Office Equipment/Supplies/Services
  • Sector
  • RGEN Health Care
  • ESAB Industrials
  • Exchange
  • RGEN Nasdaq
  • ESAB Nasdaq
  • Market Cap
  • RGEN 8.0B
  • ESAB 6.9B
  • IPO Year
  • RGEN N/A
  • ESAB N/A
  • Fundamental
  • Price
  • RGEN $128.04
  • ESAB $128.89
  • Analyst Decision
  • RGEN Buy
  • ESAB Buy
  • Analyst Count
  • RGEN 12
  • ESAB 8
  • Target Price
  • RGEN $172.67
  • ESAB $136.13
  • AVG Volume (30 Days)
  • RGEN 830.2K
  • ESAB 275.3K
  • Earning Date
  • RGEN 04-29-2025
  • ESAB 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • ESAB 0.31%
  • EPS Growth
  • RGEN N/A
  • ESAB 16.34
  • EPS
  • RGEN N/A
  • ESAB 4.43
  • Revenue
  • RGEN $650,429,000.00
  • ESAB $2,729,197,000.00
  • Revenue This Year
  • RGEN $13.93
  • ESAB N/A
  • Revenue Next Year
  • RGEN $14.35
  • ESAB $5.05
  • P/E Ratio
  • RGEN N/A
  • ESAB $29.08
  • Revenue Growth
  • RGEN 4.88
  • ESAB N/A
  • 52 Week Low
  • RGEN $102.97
  • ESAB $88.54
  • 52 Week High
  • RGEN $182.52
  • ESAB $135.97
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.98
  • ESAB 63.50
  • Support Level
  • RGEN $123.10
  • ESAB $120.56
  • Resistance Level
  • RGEN $135.47
  • ESAB $132.55
  • Average True Range (ATR)
  • RGEN 6.85
  • ESAB 3.63
  • MACD
  • RGEN -0.74
  • ESAB 1.13
  • Stochastic Oscillator
  • RGEN 19.54
  • ESAB 77.50

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ESAB ESAB Corporation

ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.

Share on Social Networks: